Status:
COMPLETED
HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis
Lead Sponsor:
Changhai Hospital
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
* Molecules indicating endothelial injury may serve as biomarkers for severe sepsis because of the critical role of endothelial injury in organ dysfunction during severe sepsis. * HSPA12B is primarily...
Eligibility Criteria
Inclusion
- Adult patients
- Patients meet the diagnostic criteria according to the grouping
Exclusion
- patients without informed consent
- patients who were undergoing continuous renal replacement therapy before sampling
- patients with special infection induced by virus, tubercle bacillus, mycoplasma, Chlamydia, and so on
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT01847248
Start Date
May 1 2011
End Date
October 1 2013
Last Update
November 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Care Medicine, Changhai Hospital
Shanghai, China, 200433